A novel signature constructed by mitochondrial function and cell death-related gene for the prediction of prognosis in bladder cancer

Abstract Bladder urothelial carcinoma (BLCA) presents a persistent challenge in clinical management. Despite recent advancements demonstrating the BLCA efficacy of immune checkpoint inhibitors (ICI) in BLCA patients, there remains a critical need to identify and expand the subset of individuals who...

Full description

Bibliographic Details
Main Authors: Zhiwei Yan, Yunxun Liu, Minghui Wang, Lei Wang, Zhiyuan Chen, Xiuheng Liu
Format: Article
Language:English
Published: Nature Portfolio 2024-06-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-65594-0